2/6/26 18:38 | 2/4/26 | RYTM | Rhythm Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Smith Hunter C | MA | O | CFO | 2 | S.dm | -703 | 21.54 | 0 | -33 | | 132 | D | | | | | | | | | | | | | | |
2/6/26 17:54 | 2/6/26 | SNDX | Syndax Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Metzger Michael A | NY | DO | CEO | 1 | S.d | -153 | 20.62 | 0 | -7 | | 509 | D | | | | | | | | | | | | | | |
2/6/26 17:53 | 2/6/26 | SNDX | Syndax Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Goldan Keith A. | NY | O | CFO | 1 | S.d | -43 | 20.62 | 0 | -2 | | 144 | D | | | | | | | | | | | | | | |
2/6/26 17:46 | 2/5/26 | JNJ | Johnson & Johnson | NJ | Health | Drug | Pharmaceutical Preparations | Forminard Elizabeth | NJ | O | EVP,GC | 1 | M.d | 1,155 | 129.51 | 0 | 9 | 135 | 16 | D | | | | | | | | | | | | | | |
2/6/26 16:57 | 2/4/26 | ONC | Beone Medicines Ltd. | | Health | Drug | Pharmaceutical Preparations | Lee Chan Henry | V8 | O | SVP,GC | 8 | M.dm | 2,125 | 266.65 | 0 | 8 | 4 | 223 | D | | | | | | | | | | | | | | |
2/6/26 16:57 | 2/4/26 | ONC | Beone Medicines Ltd. | | Health | Drug | Pharmaceutical Preparations | Lee Chan Henry | V8 | O | SVP,GC | 8 | S.dm | -2,125 | 266.65 | 0 | -8 | | 223 | D | | | | | | | | | | | | | | |
2/6/26 16:38 | 12/19/25 | PTGX | Protagonist Therapeutics, Inc | DE | Health | Drug | Pharmaceutical Preparations | Waddill William D. | CA | D | | 3 | S.d | -2,406 | 49.74 | 0 | -48 | | 64 | D | | | | | | | | | | | | | | |
2/6/26 16:20 | 2/6/26 | MRK | Merck & Co., Inc. | NJ | Health | Drug | Pharmaceutical Preparations | Williams David Michael | NJ | O | EVP,Chie | 2 | M.d | 998 | 99.76 | 0 | 10 | 48 | 31 | D | | | | | | | | | | | | | | |
2/6/26 16:20 | 2/6/26 | MRK | Merck & Co., Inc. | NJ | Health | Drug | Pharmaceutical Preparations | Williams David Michael | NJ | O | EVP,Chie | 2 | S.d | -998 | 99.76 | 0 | -10 | | 31 | D | | | | | | | | | | | | | | |
2/6/26 16:18 | 2/5/26 | INSM | Insmed Inc | VA | Health | Drug | Pharmaceutical Preparations | Flammer Martina M.D. | NJ | O | Chief Me | 12 | S.dm | -16,457 | 110.11 | 0 | -149 | | 95 | D | | | | | | | | | | | | | | |
2/6/26 16:18 | 2/4/26 | MRK | Merck & Co., Inc. | NJ | Health | Drug | Pharmaceutical Preparations | Smart Dalton E. III | NJ | O | SVP Fin. | 2 | M.d | 1,014 | 97.52 | 0 | 10 | | 8 | D | | | | | | | | | | | | | | |
2/6/26 16:18 | 2/4/26 | MRK | Merck & Co., Inc. | NJ | Health | Drug | Pharmaceutical Preparations | Smart Dalton E. III | NJ | O | SVP Fin. | 2 | S.d | -1,014 | 97.52 | 0 | -10 | | 8 | D | | | | | | | | | | | | | | |
2/6/26 16:15 | 2/6/26 | MRK | Merck & Co., Inc. | NJ | Health | Drug | Pharmaceutical Preparations | Oosthuizen Johannes Jacobus | NJ | O | P,U.S. M | 1 | S | -1,828 | 121.87 | 0 | -15 | | 21 | D | | | | | | | | | | | | | | |
2/6/26 16:13 | 2/4/26 | MRK | Merck & Co., Inc. | NJ | Health | Drug | Pharmaceutical Preparations | Litchfield Caroline | NJ | O | EVP,CFO | 2 | M.d | 7,252 | 86.34 | 0 | 84 | 999% | 90 | D | | | | | | | | | | | | | | |
2/6/26 16:13 | 2/4/26 | MRK | Merck & Co., Inc. | NJ | Health | Drug | Pharmaceutical Preparations | Litchfield Caroline | NJ | O | EVP,CFO | 2 | S.d | -7,252 | 86.34 | 0 | -84 | | 90 | D | | | | | | | | | | | | | | |
2/6/26 16:12 | 2/4/26 | MRK | Merck & Co., Inc. | NJ | Health | Drug | Pharmaceutical Preparations | Li Dean Y | NJ | O | EVP,P,MR | 2 | M.d | 2,637 | 87.40 | 0 | 30 | 42 | 102 | D | | | | | | | | | | | | | | |
2/6/26 16:12 | 2/4/26 | MRK | Merck & Co., Inc. | NJ | Health | Drug | Pharmaceutical Preparations | Li Dean Y | NJ | O | EVP,P,MR | 2 | S.d | -2,637 | 87.40 | 0 | -30 | | 102 | D | | | | | | | | | | | | | | |
2/6/26 16:10 | 2/5/26 | MRK | Merck & Co., Inc. | NJ | Health | Drug | Pharmaceutical Preparations | Guindo Chirfi | NJ | O | CMO | 1 | S | -2,438 | 121.88 | 0 | -20 | | 81 | D | | | | | | | | | | | | | | |
2/6/26 16:08 | 2/6/26 | MRK | Merck & Co., Inc. | NJ | Health | Drug | Pharmaceutical Preparations | Deluca Richard R. | NJ | O | EVP,P,Me | 1 | S | -4,557 | 120.92 | 0 | -38 | | 160 | D | | | | | | | | | | | | | | |
2/6/26 16:05 | 2/4/26 | MRK | Merck & Co., Inc. | NJ | Health | Drug | Pharmaceutical Preparations | Davis Robert M | NJ | DO | CB,CEO,P | 1 | S | -5,599 | 118.04 | 0 | -47 | | 444 | D | | | | | | | | | | | | | | |
2/6/26 08:04 | 2/4/26 | ABT | Abbott Laboratories | IL | Health | Drug | Pharmaceutical Preparations | Starks Daniel J | IL | D | | 1 | P | 1,087 | 108.73 | 0 | 10 | 0 | 6,739 | D | | | | | | | | | | | | | | |
2/5/26 20:17 | 2/5/26 | CYTK | Cytokinetics Inc | | Health | Drug | Pharmaceutical Preparations | Callos Andrew | CA | O | EVP,Chie | 13 | M.d | 8,225 | 47.46 | 0 | 173 | | 51 | D | | | | | | | | | | | | | | |
2/5/26 20:17 | 2/5/26 | CYTK | Cytokinetics Inc | | Health | Drug | Pharmaceutical Preparations | Callos Andrew | CA | O | EVP,Chie | 13 | S.d | -8,225 | 47.46 | 0 | -173 | | 51 | D | | | | | | | | | | | | | | |
2/5/26 19:22 | 2/3/26 | PAHC | Phibro Animal Health Corp | DE | Health | Drug | Pharmaceutical Preparations | Bendheim Jack | NJ | DOT | P,CEO | 15 | S.dm | -6,425 | 42.33 | 0 | -152 | | 67 | I | | | | | | | | | | | | | | |
2/5/26 19:04 | 1/5/26 | MANE | Veradermics, Inc | DE | Health | Drug | Pharmaceutical Preparations | Coric Vlad | CT | D | | 3 | M.d | 7,000 | 8.77 | 0 | 799 | 23 | 4,299 | D | | | | | | | | | | | | | | |
2/5/26 19:04 | 2/5/26 | BHVN | Biohaven Ltd. | D8 | Health | Drug | Pharmaceutical Preparations | Childs John W | CT | D | | 2 | P.d | 30,000 | 8.27 | 0 | 3,627 | 43 | 12,079 | I | | | | | | | | | | | | | | |
2/5/26 19:03 | 2/5/26 | MANE | Veradermics, Inc | DE | Health | Drug | Pharmaceutical Preparations | Longitude Capital Partners V, LLC | CA | T | | 1 | P.d | 18,275 | 17.00 | 0 | 1,075 | 110 | 2,053 | I | | | | | | | | | | | | | | |
2/5/26 19:03 | 2/5/26 | MANE | Veradermics, Inc | DE | Health | Drug | Pharmaceutical Preparations | Enright Patrick G | CA | DT | | 2 | P.d | 18,525 | 17.14 | 0 | 1,081 | 17 | 7,454 | I | | | | | | | | | | | | | | |
2/5/26 19:00 | 2/3/26 | PMN | Promis Neurosciences Inc. | Z4 | Health | Drug | Pharmaceutical Preparations | Abg Management Ltd. | K3 | T | | 1 | P.d | 8,500 | 12.13 | 0 | 701 | 289 | 943 | I | | | | | | | | | | | | | | |
2/5/26 17:42 | 2/3/26 | CORT | Corcept Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Guyer William | CA | O | Chief De | 8 | M.d | 5,150 | 39.92 | 0 | 129 | | 1 | D | | | | | | | | | | | | | | |
2/5/26 17:42 | 2/3/26 | CORT | Corcept Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Guyer William | CA | O | Chief De | 8 | S.d | -5,150 | 39.92 | 0 | -129 | | 1 | D | | | | | | | | | | | | | | |
2/5/26 16:48 | 2/3/26 | ACRS | Aclaris Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Loerop James | PA | O | Chief Bu | 3 | M.dm | 0 | 0.00 | 0 | 146 | 318 | 192 | D | | | | | | | | | | | | | | |
2/5/26 16:45 | 2/3/26 | ACRS | Aclaris Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Walker Neal | PA | DO | CEO | 2 | M.d | 0 | 0.00 | 0 | 93 | 6 | 1,544 | D | | | | | | | | | | | | | | |
2/5/26 16:44 | 2/3/26 | ACRS | Aclaris Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Davis Hugh M. | PA | DO | P,COO | 2 | M.d | 0 | 0.00 | 0 | 45 | | 45 | D | | | | | | | | | | | | | | |
2/5/26 16:41 | 2/3/26 | ACRS | Aclaris Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Balthaser Kevin | PA | O | CFO | 3 | M.dm | 0 | 0.00 | 0 | 131 | 241 | 186 | D | | | | | | | | | | | | | | |
2/5/26 16:31 | 2/5/26 | UTHR | United Therapeutics Corp | DE | Health | Drug | Pharmaceutical Preparations | Mahon Paul A | MD | O | EVP,GC | 14 | M.d | 43,203 | 313.52 | 0 | 138 | | 37 | D | | | | | | | | | | | | | | |
2/5/26 16:31 | 2/5/26 | UTHR | United Therapeutics Corp | DE | Health | Drug | Pharmaceutical Preparations | Mahon Paul A | MD | O | EVP,GC | 14 | S.d | -43,203 | 313.52 | 0 | -138 | | 37 | D | | | | | | | | | | | | | | |
2/5/26 16:24 | 2/3/26 | CTNM | Contineum Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lorrain Daniel S. | CA | O | Chief Sc | 3 | S | -157 | 12.54 | 0 | -13 | | 171 | D | | | | | | | | | | | | | | |
2/5/26 16:14 | 2/3/26 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Francois Cedric | MA | DO | CEO | 4 | M.d | 1,013 | 18.62 | 0 | 54 | 3 | 1,805 | D | | | | | | | | | | | | | | |
2/5/26 16:10 | 2/4/26 | VSTM | Verastem, Inc. | MA | Health | Drug | Pharmaceutical Preparations | Paterson Dan | MA | DO | P,CEO | 8 | S.m | -370 | 9.34 | 0 | -40 | | 613 | D | | | | | | | | | | | | | | |
2/5/26 16:05 | 2/4/26 | TVTX | Travere Therapeutics, Inc. | CA | Health | Drug | Pharmaceutical Preparations | Inrig Jula | CA | O | Chief Me | 5 | S.dm | -1,143 | 27.74 | 0 | -41 | | 107 | D | | | | | | | | | | | | | | |
2/5/26 16:05 | 2/4/26 | TVTX | Travere Therapeutics, Inc. | CA | Health | Drug | Pharmaceutical Preparations | Cline Christopher R. | CA | O | CFO | 4 | S.d | -1,314 | 26.81 | 0 | -49 | | 113 | D | | | | | | | | | | | | | | |
2/5/26 16:05 | 2/4/26 | TVTX | Travere Therapeutics, Inc. | CA | Health | Drug | Pharmaceutical Preparations | Reed Elizabeth E | CA | O | GC,GC | 4 | S.d | -791 | 26.22 | 0 | -30 | | 108 | D | | | | | | | | | | | | | | |
2/5/26 10:18 | 2/3/26 | CLNN | Clene Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ugwumba Chidozie | AR | T | | 13 | S.dm | -3,144 | 5.99 | 0 | -525 | | 796 | I | | | | | | | | | | | | | | |
2/5/26 06:30 | 2/2/26 | SPRO | Spero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Keutzer Timothy | MA | O | COO | 1 | S.dm | -101 | 2.17 | 0 | -47 | | 761 | D | | | | | | | | | | | | | | |
2/4/26 21:44 | 2/2/26 | SPRO | Spero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rajavelu Esther | MA | O | See Rema | 2 | S.d | -136 | 2.32 | 0 | -59 | | 1,100 | D | | | | | | | | | | | | | | |
2/4/26 21:33 | 2/2/26 | SYRE | Spyre Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Turtle Cameron | MA | DO | CEO | 3 | S | -1,388 | 30.83 | 0 | -45 | | 687 | D | | | | | | | | | | | | | | |
2/4/26 21:15 | 2/2/26 | MPLT | Maplight Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Malenka Robert C. | CA | D | | 2 | S.m | -763 | 18.41 | 0 | -41 | | 397 | D | | | | | | | | | | | | | | |
2/4/26 20:35 | 12/1/25 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Matsuda Masaru | CA | O | See Rema | 3 | S | -1,150 | 25.63 | 0 | -45 | | 151 | D | | | | | | | | | | | | | | |
2/4/26 20:27 | 2/2/26 | ZNTL | Zentalis Pharmaceuticals, Inc. | | Health | Drug | Pharmaceutical Preparations | Vultaggio Vincent | CA | O | PAO,PFO | 1 | S.m | -8 | 2.54 | 0 | -3 | | 187 | D | | | | | | | | | | | | | | |
2/4/26 20:23 | 2/2/26 | OCUL | Ocular Therapeutix, Inc | DE | Health | Drug | Pharmaceutical Preparations | Notman Donald | MA | O | COO | 1 | S.m | -101 | 8.82 | 0 | -11 | | 378 | D | | | | | | | | | | | | | | |
2/4/26 20:12 | 2/3/26 | TNGX | Tango Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Beckman Daniella | MA | O | CFO | 1 | S.d | -127 | 12.26 | 0 | -10 | | 184 | D | | | | | | | | | | | | | | |
2/4/26 20:09 | 2/3/26 | TNGX | Tango Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Weber Barbara | MA | DO | Dir,Exec | 1 | S.d | -374 | 12.26 | 0 | -31 | | 1,629 | D | | | | | | | | | | | | | | |
2/4/26 20:02 | 2/3/26 | TNGX | Tango Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Crystal Adam | MA | O | P,R,D | 1 | S.d | -226 | 12.26 | 0 | -18 | | 187 | D | | | | | | | | | | | | | | |
2/4/26 19:43 | 2/2/26 | SION | Sionna Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Thompson Peter A. | MA | D | | 5 | S.dm | -8,883 | 23.12 | 0 | -384 | | 12,416 | I | | | | | | | | | | | | | | |
2/4/26 19:39 | 2/2/26 | SION | Sionna Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Orbimed Advisors LLC | NY | D | | 4 | S.m | -7,764 | 44.55 | 0 | -174 | | 3,597 | I | | | | | | | | | | | | | | |
2/4/26 19:37 | 2/3/26 | URGN | Urogen Pharma Ltd. | L3 | Health | Drug | Pharmaceutical Preparations | Schoenberg Mark | NJ | O | Chief Me | 3 | S.d | -395 | 12.87 | 0 | -31 | | 145 | D | | | | | | | | | | | | | | |
2/4/26 19:30 | 12/15/25 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Burnett Patrick | CA | O | See Rema | 5 | M.dm | 843 | 20.73 | 0 | 41 | 71 | 98 | D | | | | | | | | | | | | | | |
2/4/26 19:30 | 12/15/25 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Burnett Patrick | CA | O | See Rema | 5 | S.dm | -843 | 20.73 | 0 | -41 | | 98 | D | | | | | | | | | | | | | | |
2/4/26 19:25 | 11/21/25 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd | CA | DO | See Rema | 2 | S.m | -2,023 | 28.97 | 0 | -70 | | 974 | D | | | | | | | | | | | | | | |
2/4/26 19:24 | 2/2/26 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Vairavan Latha | CA | O | SVP CFO | 1 | S | -34 | 25.50 | 0 | -1 | | 64 | D | | | | | | | | | | | | | | |
2/4/26 19:23 | 12/1/25 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | 3 | S | -842 | 28.07 | 0 | -30 | | 80 | D | | | | | | | | | | | | | | |
2/4/26 19:21 | 2/2/26 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Edwards Larry Todd | CA | O | See Rema | 1 | S | -52 | 25.50 | 0 | -2 | | 149 | D | | | | | | | | | | | | | | |
2/4/26 18:24 | 2/2/26 | KNSA | Kiniksa Pharmaceuticals International, Plc | | Health | Drug | Pharmaceutical Preparations | Quart Barry D | X0 | D | | 4 | M.dm | 2,013 | 27.88 | 0 | 72 | | 13 | D | | | | | | | | | | | | | | |
2/4/26 18:24 | 2/2/26 | KNSA | Kiniksa Pharmaceuticals International, Plc | | Health | Drug | Pharmaceutical Preparations | Quart Barry D | X0 | D | | 4 | S.dm | -2,013 | 27.88 | 0 | -72 | | 13 | D | | | | | | | | | | | | | | |
2/4/26 18:20 | 1/26/26 | KNSA | Kiniksa Pharmaceuticals International, Plc | | Health | Drug | Pharmaceutical Preparations | Levy Richard S | X0 | D | | 4 | M.d | 4,611 | 212.66 | 0 | 22 | 96 | 44 | D | | | | | | | | | | | | | | |
2/4/26 17:31 | 2/3/26 | IGC | Igc Pharma, Inc. | MD | Health | Drug | Pharmaceutical Preparations | Mukunda Ram | MD | DO | CEO | 1 | M.d | 0 | 0.00 | 0 | 50 | 6 | 861 | I | | | | | | | | | | | | | | |
2/4/26 17:18 | 2/2/26 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Kozarich John W | FL | D | | 3 | S | -271 | 193.78 | 0 | -1 | | 44 | D | | | | | | | | | | | | | | |
2/4/26 17:09 | 1/1/26 | PCSA | Processa Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young David | FL | DO | P Resear | 1 | M.d | 0 | 0.00 | 0 | 0 | 0 | 11 | D | | | | | | | | | | | | | | |
2/4/26 17:07 | 2/2/26 | RPRX | Royalty Pharma Plc | X0 | Health | Drug | Pharmaceutical Preparations | Coyne Terrance P. | NY | O | EVP,CFO | 7 | S.m | -26,633 | 40.29 | 0 | -661 | | 829 | I | | | | | | | | | | | | | | |
2/4/26 17:07 | 1/1/26 | PCSA | Processa Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lin Patrick | FL | O | Chief Bu | 1 | M.d | 0 | 0.00 | 0 | 0 | 6 | 3 | D | | | | | | | | | | | | | | |
2/4/26 17:05 | 1/1/26 | PCSA | Processa Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Guy Wendy | FL | O | Chief Ad | 1 | M.d | 0 | 0.00 | 0 | 0 | 14 | 2 | D | | | | | | | | | | | | | | |
2/4/26 17:04 | 1/1/26 | PCSA | Processa Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bigora Sian | FL | O | Chief De | 1 | M.d | 0 | 0.00 | 0 | 0 | 15 | 2 | D | | | | | | | | | | | | | | |
2/4/26 16:32 | 12/5/25 | BOLT | Bolt Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Quinn William P. | CA | DO | P,CEO,CF | 1 | P.d | 1 | 4.61 | 0 | 0 | 6 | 2 | D | | | | | | | | | | | | | | |
2/4/26 16:32 | 12/5/25 | BOLT | Bolt Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Nemec Sarah | CA | O | SVP,Fina | 1 | P.d | 1 | 4.61 | 0 | 0 | 10 | 1 | D | | | | | | | | | | | | | | |
2/4/26 16:30 | 2/2/26 | ABEO | Abeona Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Silverstein Christine Berni | OH | D | | 1 | S | -102 | 5.09 | 0 | -20 | | 138 | D | | | | | | | | | | | | | | |
2/4/26 16:27 | 2/3/26 | ZVRA | Zevra Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sangiovanni Timothy J. | FL | O | SVP,Fina | 3 | S.dm | -43 | 1.89 | 0 | -23 | | 33 | D | | | | | | | | | | | | | | |
2/4/26 16:27 | 2/3/26 | ZVRA | Zevra Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schafer Joshua | FL | O | CCO | 3 | S.dm | -126 | 2.09 | 0 | -61 | | 73 | D | | | | | | | | | | | | | | |
2/4/26 16:25 | 2/3/26 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Smethurst Dominic | MA | O | Chief Me | 1 | S | -27 | 8.09 | 0 | -3 | | 96 | D | | | | | | | | | | | | | | |
2/4/26 16:25 | 2/2/26 | LXRX | Lexicon Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Invus Global Management, LLC | NY | DT | | 1 | P | 2,000 | 1.30 | 0 | 1,538 | 4 | 44,145 | I | | | | | | | | | | | | | | |
2/4/26 16:24 | 2/3/26 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hodgson Ian | MA | O | COO | 1 | S | -20 | 8.09 | 0 | -2 | | 52 | D | | | | | | | | | | | | | | |
2/4/26 16:20 | 1/26/26 | RIGL | Rigel Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Rodriguez Raul R | CA | DO | CEO,P | 1 | M.d | 2,192 | 27.40 | 0 | 80 | 51 | 236 | D | | | | | | | | | | | | | | |
2/4/26 16:20 | 2/3/26 | INSM | Insmed Inc | VA | Health | Drug | Pharmaceutical Preparations | Adsett Roger | NJ | O | COO | 2 | S.m | -870 | 171.27 | 0 | -5 | | 108 | D | | | | | | | | | | | | | | |
2/4/26 16:19 | 2/3/26 | INSM | Insmed Inc | VA | Health | Drug | Pharmaceutical Preparations | Bonstein Sara | NJ | O | CFO | 2 | S.m | -926 | 171.74 | 0 | -5 | | 81 | D | | | | | | | | | | | | | | |
2/4/26 16:17 | 12/18/25 | INSM | Insmed Inc | VA | Health | Drug | Pharmaceutical Preparations | Lewis William | NJ | DO | Chair,CE | 10 | M.dm | 12,156 | 113.83 | 0 | 107 | 22 | 600 | D | | | | | | | | | | | | | | |
2/4/26 16:17 | 12/18/25 | INSM | Insmed Inc | VA | Health | Drug | Pharmaceutical Preparations | Lewis William | NJ | DO | Chair,CE | 10 | S.dm | -12,156 | 113.83 | 0 | -107 | | 600 | D | | | | | | | | | | | | | | |
2/4/26 16:15 | 2/2/26 | ALXO | Alx Oncology Holdings Inc | DE | Health | Drug | Pharmaceutical Preparations | Goodman Corey S | CA | DT | | 1 | P | 5,000 | 1.57 | 0 | 3,185 | 32 | 13,052 | I | | | | | | | | | | | | | | |
2/4/26 16:15 | 2/3/26 | INSM | Insmed Inc | VA | Health | Drug | Pharmaceutical Preparations | Smith Michael Alexander | NJ | O | GC | 2 | S.m | -650 | 171.01 | 0 | -4 | | 57 | D | | | | | | | | | | | | | | |
2/4/26 16:15 | 2/2/26 | AKBA | Akebia Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Malabre Richard C | MA | O | SVP,Chie | 1 | S | -69 | 1.39 | 0 | -50 | | 299 | D | | | | | | | | | | | | | | |
2/4/26 16:15 | 1/2/26 | FULC | Fulcrum Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gould Robert J | MA | D | | 4 | S | -668 | 11.13 | 0 | -60 | | 485 | D | | | | | | | | | | | | | | |
2/4/26 16:13 | 2/2/26 | AKBA | Akebia Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Grund Nicholas | MA | O | Chief Co | 1 | S | -118 | 1.39 | 0 | -85 | | 562 | D | | | | | | | | | | | | | | |
2/4/26 16:13 | 2/2/26 | AKBA | Akebia Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Burke Steven Keith | MA | O | SVP,Chie | 1 | S | -94 | 1.39 | 0 | -68 | | 948 | D | | | | | | | | | | | | | | |
2/4/26 16:12 | 2/2/26 | AKBA | Akebia Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rucci Carolyn M. | MA | O | SVP,GC | 1 | S | -97 | 1.39 | 0 | -70 | | 588 | D | | | | | | | | | | | | | | |
2/4/26 16:11 | 2/3/26 | KPTI | Karyopharm Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Macomber Lori | MA | O | EVP,CFO, | 1 | S | -10 | 6.30 | 0 | -2 | | 85 | D | | | | | | | | | | | | | | |
2/4/26 16:11 | 2/2/26 | AKBA | Akebia Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ostrowski Erik | MA | O | SVP,CFO, | 1 | S | -49 | 1.39 | 0 | -35 | | 673 | D | | | | | | | | | | | | | | |
2/4/26 16:10 | 2/2/26 | AKBA | Akebia Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Butler John P. | MA | DO | CEO,P | 1 | S | -474 | 1.39 | 0 | -341 | | 3,458 | D | | | | | | | | | | | | | | |
2/4/26 16:06 | 2/2/26 | IONS | Ionis Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Bennett C Frank | CA | O | EVP,Chie | 5 | S.d | -11,717 | 62.96 | 0 | -186 | | 100 | D | | | | | | | | | | | | | | |
2/4/26 16:06 | 2/2/26 | IONS | Ionis Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Bennett C Frank | CA | O | EVP,Chie | 5 | M.d | 11,717 | 62.96 | 0 | 186 | | 100 | D | | | | | | | | | | | | | | |
2/4/26 16:05 | 2/2/26 | SLGL | Sol-Gel Technologies Ltd. | L3 | Health | Drug | Pharmaceutical Preparations | Opaleye Management Inc. | MA | T | | 13 | P.m | 4,924 | 43.78 | 0 | 112 | 3 | 4,346 | I | | | | | | | | | | | | | | |
2/4/26 16:05 | 2/2/26 | GBIO | Generation Bio Co. | | Health | Drug | Pharmaceutical Preparations | Conway Kevin John | MA | O | CFO | 2 | M.d | 0 | 0.00 | 0 | 0 | 17 | 2 | D | | | | | | | | | | | | | | |
2/4/26 16:05 | 2/2/26 | GBIO | Generation Bio Co. | DE | Health | Drug | Pharmaceutical Preparations | McDonough Geoff | MA | D | | 3 | M.d | 0 | 0.00 | 0 | 3 | 1 | 189 | D | | | | | | | | | | | | | | |
2/4/26 16:05 | 2/2/26 | GBIO | Generation Bio Co. | | Health | Drug | Pharmaceutical Preparations | Howze Yalonda | MA | O | INTERIM | 2 | M.d | 0 | 0.00 | 0 | 2 | 115 | 4 | D | | | | | | | | | | | | | | |
2/4/26 16:05 | 2/2/26 | AMLX | Amylyx Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Frates James M | MA | O | CFO | 2 | S | -89 | 12.94 | 0 | -7 | | 304 | D | | | | | | | | | | | | | | |
2/4/26 16:05 | 2/2/26 | AMLX | Amylyx Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cohen Joshua B | MA | DO | Co-CEO | 4 | S.dm | -3,705 | 10.25 | 0 | -361 | | 3,379 | D | | | | | | | | | | | | | | |
2/4/26 16:05 | 2/2/26 | AMLX | Amylyx Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mazzariello Gina | MA | O | GC | 1 | S | -51 | 14.65 | 0 | -3 | | 145 | D | | | | | | | | | | | | | | |
2/4/26 16:05 | 2/2/26 | AMLX | Amylyx Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Klee Justin B. | MA | DO | Co-CEO | 4 | S.dm | -3,705 | 10.25 | 0 | -361 | | 3,379 | D | | | | | | | | | | | | | | |
2/3/26 21:45 | 2/2/26 | MIRM | Mirum Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Radovich Peter | CA | O | P,COO | 5 | S.d | -796 | 44.07 | 0 | -18 | | 23 | D | | | | | | | | | | | | | | |
2/3/26 21:45 | 2/2/26 | MIRM | Mirum Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Peetz Christopher | CA | DO | CEO | 6 | S.d | -2,629 | 38.96 | 0 | -67 | | 367 | D | | | | | | | | | | | | | | |
2/3/26 21:45 | 1/31/26 | MIRM | Mirum Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Howe Jolanda | CA | O | SVP,GLOB | 6 | M.d | 267 | 35.42 | 0 | 8 | | 5 | D | | | | | | | | | | | | | | |
2/3/26 21:45 | 2/2/26 | MIRM | Mirum Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Howe Jolanda | CA | O | SVP,GLOB | 6 | S.d | -267 | 35.42 | 0 | -8 | | 5 | D | | | | | | | | | | | | | | |
2/3/26 21:30 | 2/3/26 | TVTX | Travere Therapeutics, Inc. | CA | Health | Drug | Pharmaceutical Preparations | Dube Eric M | CA | DO | CEO | 3 | S.dm | -5,963 | 27.09 | 0 | -220 | | 433 | D | | | | | | | | | | | | | | |
2/3/26 21:30 | 2/3/26 | TVTX | Travere Therapeutics, Inc. | CA | Health | Drug | Pharmaceutical Preparations | Heerma Peter | CA | O | Chief Co | 2 | S.d | -434 | 35.31 | 0 | -12 | | 132 | D | | | | | | | | | | | | | | |
2/3/26 21:30 | 2/3/26 | TVTX | Travere Therapeutics, Inc. | CA | Health | Drug | Pharmaceutical Preparations | Rote William E. | CA | O | Chief Re | 3 | S.d | -4,052 | 30.59 | 0 | -132 | | 109 | D | | | | | | | | | | | | | | |
2/3/26 21:30 | 2/3/26 | TVTX | Travere Therapeutics, Inc. | CA | Health | Drug | Pharmaceutical Preparations | Calvin Sandra | CA | O | SVP,Chie | 3 | S.d | -540 | 36.87 | 0 | -15 | | 49 | D | | | | | | | | | | | | | | |
2/3/26 21:12 | 2/3/26 | NRIX | Nurix Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | 3 | M.d | 108 | 2.24 | 0 | 48 | 72 | 115 | D | | | | | | | | | | | | | | |
2/3/26 19:53 | 1/31/26 | AVIR | Atea Pharmaceuticals, Inc. | MA | Health | Drug | Pharmaceutical Preparations | Horga Maria Arantxa | MA | O | Chief Me | 1 | M.d | 0 | 0.00 | 0 | 51 | 114 | 96 | D | | | | | | | | | | | | | | |
2/3/26 19:47 | 1/31/26 | AVIR | Atea Pharmaceuticals, Inc. | MA | Health | Drug | Pharmaceutical Preparations | Vavricka John | MA | O | Chief Co | 1 | M.d | 0 | 0.00 | 0 | 42 | 34 | 165 | D | | | | | | | | | | | | | | |
2/3/26 19:46 | 1/31/26 | AVIR | Atea Pharmaceuticals, Inc. | MA | Health | Drug | Pharmaceutical Preparations | Hammond Janet Mj | MA | O | Chief De | 1 | M.d | 0 | 0.00 | 0 | 58 | 83 | 128 | D | | | | | | | | | | | | | | |
2/3/26 19:46 | 1/31/26 | AVIR | Atea Pharmaceuticals, Inc. | MA | Health | Drug | Pharmaceutical Preparations | Corcoran Andrea | MA | O | See Rema | 1 | M.d | 0 | 0.00 | 0 | 55 | 8 | 764 | D | | | | | | | | | | | | | | |
2/3/26 19:46 | 1/31/26 | AVIR | Atea Pharmaceuticals, Inc. | MA | Health | Drug | Pharmaceutical Preparations | Sommadossi Jean-Pierre | MA | DO | P,CEO,,C | 1 | M.dm | 372 | 0.6492 | 0 | 573 | 9 | 6,634 | D | | | | | | | | | | | | | | |
2/3/26 19:42 | 1/31/26 | AVIR | Atea Pharmaceuticals, Inc. | MA | Health | Drug | Pharmaceutical Preparations | Foster Wayne | MA | O | EVP,Chie | 1 | M.d | 0 | 0.00 | 0 | 41 | 109 | 79 | D | | | | | | | | | | | | | | |
2/3/26 19:00 | 1/31/26 | AMRN | Amarin Corp Plcuk | X0 | Health | Drug | Pharmaceutical Preparations | Berg Aaron | NJ | O | P,CEO | 1 | M.d | 0 | 0.00 | 0 | 4 | 5 | 83 | D | | | | | | | | | | | | | | |
2/3/26 19:00 | 1/31/26 | AMRN | Amarin Corp Plcuk | X0 | Health | Drug | Pharmaceutical Preparations | Fishman Peter L. | NJ | O | SVP,CFO | 2 | M.d | 0 | 0.00 | 0 | 5 | 369 | 6 | D | | | | | | | | | | | | | | |
2/3/26 19:00 | 1/31/26 | AMRN | Amarin Corp Plcuk | X0 | Health | Drug | Pharmaceutical Preparations | Ketchum Steven B | NJ | O | EVP,Chie | 2 | M.d | 0 | 0.00 | 0 | 8 | 24 | 41 | D | | | | | | | | | | | | | | |
2/3/26 19:00 | 1/31/26 | AMRN | Amarin Corp Plcuk | X0 | Health | Drug | Pharmaceutical Preparations | Keenan David Paul | NJ | O | EVP,COO | 2 | M.d | 0 | 0.00 | 0 | 8 | 205 | 12 | D | | | | | | | | | | | | | | |
2/3/26 18:59 | 1/30/26 | CNTA | Centessa Pharmaceuticals Plc | X0 | Health | Drug | Pharmaceutical Preparations | Hussain Iqbal J | X0 | O | GC | 3 | S.dm | -1,206 | 23.21 | 0 | -52 | | 123 | D | | | | | | | | | | | | | | |
2/3/26 18:24 | 2/2/26 | PCRX | Pacira Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Riker Lauren | CA | O | SVP,Fina | 2 | S | -118 | 21.71 | 0 | -5 | | 59 | D | | | | | | | | | | | | | | |
2/3/26 18:24 | 2/2/26 | PCRX | Pacira Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Williams Kristen | CA | O | Chief Ad | 1 | S | -270 | 20.53 | 0 | -13 | | 131 | D | | | | | | | | | | | | | | |
2/3/26 16:40 | 2/1/26 | BMY | Bristol Myers Squibb Co | DE | Health | Drug | Pharmaceutical Preparations | Meyers Gregory Scott | NJ | O | EVP,Chie | 1 | M.d | 0 | 0.00 | 0 | 3 | 13 | 21 | D | | | | | | | | | | | | | | |
2/3/26 16:39 | 2/1/26 | BMY | Bristol Myers Squibb Co | DE | Health | Drug | Pharmaceutical Preparations | Hickey Benjamin | NJ | O | P,RayzeB | 1 | M.d | 0 | 0.00 | 0 | 10 | 202 | 15 | D | | | | | | | | | | | | | | |
2/3/26 16:38 | 2/1/26 | RYTM | Rhythm Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mazabraud Yann | MA | O | EVP,Head | 1 | M.d | 0 | 0.00 | 0 | 6 | 15 | 43 | D | | | | | | | | | | | | | | |
2/3/26 16:35 | 2/1/26 | RYTM | Rhythm Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shulman Joseph | MA | O | Chief Te | 1 | M.d | 0 | 0.00 | 0 | 17 | 848 | 19 | D | | | | | | | | | | | | | | |
2/3/26 16:34 | 2/1/26 | RYTM | Rhythm Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Meeker David P | MA | DO | P,CEO | 1 | M.d | 0 | 0.00 | 0 | 69 | 40 | 239 | D | | | | | | | | | | | | | | |
2/3/26 16:33 | 2/1/26 | RYTM | Rhythm Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lee Jennifer Kayden | MA | O | EVP,Head | 1 | M.d | 0 | 0.00 | 0 | 23 | | 19 | D | | | | | | | | | | | | | | |
2/3/26 16:32 | 2/1/26 | RYTM | Rhythm Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | German Christopher Paul | MA | O | Corporat | 1 | M.d | 0 | 0.00 | 0 | 4 | | 3 | D | | | | | | | | | | | | | | |
2/3/26 16:32 | 2/1/26 | LLY | Eli Lilly & Co | IN | Health | Drug | Pharmaceutical Preparations | Yuffa Ilya | IN | O | EVP,P,LL | 1 | M.ed | 0 | 0.00 | 0 | 3 | 14 | 28 | D | | | | | | | | | | | | | | |
2/3/26 16:31 | 2/1/26 | RYTM | Rhythm Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Garfield Alastair | MA | O | Chief Sc | 1 | M.d | 0 | 0.00 | 0 | 7 | 606 | 8 | D | | | | | | | | | | | | | | |
2/3/26 16:31 | 2/3/26 | UTHR | United Therapeutics Corp | DE | Health | Drug | Pharmaceutical Preparations | Malcolm Jan | MD | D | | 5 | S | -121 | 485.07 | 0 | 0 | | 0 | D | | | | | | | | | | | | | | |
2/3/26 16:31 | 2/1/26 | LLY | Eli Lilly & Co | IN | Health | Drug | Pharmaceutical Preparations | Skovronsky Daniel | IN | O | EVP,CS,P | 1 | M.ed | 0 | 0.00 | 0 | 13 | 6 | 220 | D | | | | | | | | | | | | | | |
2/3/26 16:31 | 2/2/26 | UTHR | United Therapeutics Corp | DE | Health | Drug | Pharmaceutical Preparations | Benkowitz Michael | MD | O | P,COO | 28 | M.dm | 183,761 | 314.12 | 0 | 585 | | 3 | I | | | | | | | | | | | | | | |
2/3/26 16:31 | 2/2/26 | UTHR | United Therapeutics Corp | DE | Health | Drug | Pharmaceutical Preparations | Benkowitz Michael | MD | O | P,COO | 28 | S.dm | -183,761 | 314.12 | 0 | -585 | -100 | 3 | I | | | | | | | | | | | | | | |
2/3/26 16:31 | 2/1/26 | LLY | Eli Lilly & Co | IN | Health | Drug | Pharmaceutical Preparations | Van Naarden Jacob | IN | O | EVP,P LL | 1 | M.ed | 0 | 0.00 | 0 | 4 | 15 | 31 | D | | | | | | | | | | | | | | |
2/3/26 16:30 | 2/1/26 | RYTM | Rhythm Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cramer Pamela J. | MA | O | CHRO | 7 | M.dm | 3,434 | 47.41 | 0 | 72 | | 29 | D | | | | | | | | | | | | | | |
2/3/26 16:30 | 2/2/26 | ZBIO | Zenas Biopharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moulder Leon O Jr | MA | DO | CEO | 2 | P.m | 2,663 | 16.96 | 0 | 157 | 8 | 2,132 | D | | | | | | | | | | | | | | |
2/3/26 16:29 | 2/1/26 | LLY | Eli Lilly & Co | IN | Health | Drug | Pharmaceutical Preparations | Ricks David A | IN | DO | P,Chair, | 1 | M.ed | 0 | 0.00 | 0 | 32 | 5 | 670 | D | | | | | | | | | | | | | | |
2/3/26 16:28 | 2/1/26 | LLY | Eli Lilly & Co | IN | Health | Drug | Pharmaceutical Preparations | Rau Diogo | IN | O | EVP,CIDO | 1 | M.ed | 0 | 0.00 | 0 | 4 | 21 | 22 | D | | | | | | | | | | | | | | |
2/3/26 16:27 | 2/1/26 | LLY | Eli Lilly & Co | IN | Health | Drug | Pharmaceutical Preparations | Jonsson Patrik | IN | O | EVP,P,LL | 1 | M.ed | 0 | 0.00 | 0 | 4 | 7 | 56 | D | | | | | | | | | | | | | | |
2/3/26 16:26 | 2/1/26 | LLY | Eli Lilly & Co | IN | Health | Drug | Pharmaceutical Preparations | Hernandez Edgardo | IN | O | EVP,P,Mf | 1 | M.ed | 0 | 0.00 | 0 | 4 | 9 | 43 | D | | | | | | | | | | | | | | |
2/3/26 16:26 | 2/2/26 | BIOA | Bioage Labs, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rubin Paul D | CA | O | Chief Me | 8 | M.d | 1,625 | 7.98 | 0 | 204 | | 0 | D | | | | | | | | | | | | | | |
2/3/26 16:26 | 2/2/26 | BIOA | Bioage Labs, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rubin Paul D | CA | O | Chief Me | 8 | S.d | -1,625 | 7.98 | 0 | -204 | -100 | 0 | D | | | | | | | | | | | | | | |
2/3/26 16:25 | 2/1/26 | LLY | Eli Lilly & Co | IN | Health | Drug | Pharmaceutical Preparations | Hakim Anat | IN | O | EVP,GC,S | 1 | M.ed | 0 | 0.00 | 0 | 7 | 17 | 47 | D | | | | | | | | | | | | | | |
2/3/26 16:24 | 2/1/26 | LLY | Eli Lilly & Co | IN | Health | Drug | Pharmaceutical Preparations | Dozier Eric | IN | O | EVP,Chie | 1 | M.ed | 0 | 0.00 | 0 | 3 | 32 | 12 | D | | | | | | | | | | | | | | |
2/3/26 16:23 | 2/1/26 | BIOA | Bioage Labs, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Goldstein Dov A Md | CA | O | CFO | 4 | M.d | 789 | 12.92 | 0 | 61 | | 29 | D | | | | | | | | | | | | | | |
2/3/26 16:15 | 1/30/26 | ALT | Altimmune, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Roberts M Scot | MD | O | Chief Sc | 3 | M.dm | 0 | 0.00 | 0 | 48 | 73 | 113 | D | | | | | | | | | | | | | | |
2/3/26 16:05 | 12/10/25 | AVBP | Arrivent Biopharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hillhouse Investment Management, Ltd. | E9 | T | | 1 | S | -12,983 | 23.37 | 0 | -556 | | 3,929 | I | | | | | | | | | | | | | | |
2/3/26 12:35 | 11/24/25 | SER | Serina Therapeutics, Inc. | AL | Health | Drug | Pharmaceutical Preparations | Moreadith Randall | AL | O | Chief Sc | 34 | M.dm | 275 | 1.63 | 0 | 168 | | 6 | D | | | | | | | | | | | | | | |
2/3/26 12:35 | 11/24/25 | SER | Serina Therapeutics, Inc. | AL | Health | Drug | Pharmaceutical Preparations | Moreadith Randall | AL | O | Chief Sc | 34 | S.dm | -275 | 1.63 | 0 | -168 | | 6 | D | | | | | | | | | | | | | | |
2/3/26 12:00 | 2/2/26 | RARE | Ultragenyx Pharmaceutical Inc. | DE | Health | Drug | Pharmaceutical Preparations | Horn Howard | CA | O | CFO | 3 | S | -256 | 27.57 | 0 | -9 | | 95 | D | | | | | | | | | | | | | | |
2/3/26 08:30 | 1/31/26 | HRTX | Heron Therapeutics, Inc. /De/ | DE | Health | Drug | Pharmaceutical Preparations | Duarte IRA | NC | O | EVP,CFO | 2 | M.d | 0 | 0.00 | 0 | 16 | 9 | 195 | D | | | | | | | | | | | | | | |
2/3/26 08:30 | 1/31/26 | HRTX | Heron Therapeutics, Inc. /De/ | DE | Health | Drug | Pharmaceutical Preparations | Forbes William P | NC | O | EVP,Chie | 2 | M.d | 0 | 0.00 | 0 | 16 | 9 | 182 | D | | | | | | | | | | | | | | |
2/3/26 08:30 | 1/31/26 | HRTX | Heron Therapeutics, Inc. /De/ | DE | Health | Drug | Pharmaceutical Preparations | Collard Craig A | NC | DO | CEO | 2 | M.d | 0 | 0.00 | 0 | 49 | 9 | 572 | D | | | | | | | | | | | | | | |
2/2/26 20:52 | 1/30/26 | IONS | Ionis Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Swayze Eric | CA | O | EVP Rese | 5 | S.d | -4,546 | 53.79 | 0 | -85 | | 48 | D | | | | | | | | | | | | | | |
2/2/26 20:52 | 2/2/26 | ALKS | Alkermes Plc. | | Health | Drug | Pharmaceutical Preparations | Hopkinson Craig C. | MA | O | EVP R,D, | 8 | M.d | 1,063 | 26.91 | 0 | 39 | 150 | 66 | D | | | | | | | | | | | | | | |
2/2/26 20:52 | 2/2/26 | ALKS | Alkermes Plc. | | Health | Drug | Pharmaceutical Preparations | Hopkinson Craig C. | MA | O | EVP R,D, | 8 | S.d | -1,063 | 26.91 | 0 | -39 | | 66 | D | | | | | | | | | | | | | | |
2/2/26 20:52 | 1/30/26 | IONS | Ionis Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Schneider Eugene | CA | O | EVP,Chf | 3 | S.d | -1,219 | 32.79 | 0 | -37 | | 70 | D | | | | | | | | | | | | | | |
2/2/26 20:51 | 1/30/26 | IONS | Ionis Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | O'Neil Patrick R. | CA | O | EVP CLO, | 3 | S.d | -1,213 | 32.93 | 0 | -37 | | 72 | D | | | | | | | | | | | | | | |
2/2/26 20:51 | 1/30/26 | IONS | Ionis Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Monia Brett P | CA | DO | CEO | 3 | S.d | -8,504 | 43.35 | 0 | -196 | | 284 | D | | | | | | | | | | | | | | |
2/2/26 20:51 | 1/30/26 | IONS | Ionis Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Birchler Brian | CA | O | EVP,Corp | 3 | S.d | -1,150 | 33.09 | 0 | -35 | | 66 | D | | | | | | | | | | | | | | |
2/2/26 20:51 | 1/30/26 | IONS | Ionis Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Baroldi Joseph | CA | O | EVP,Chie | 3 | S.d | -1,050 | 31.58 | 0 | -33 | | 50 | D | | | | | | | | | | | | | | |
2/2/26 20:48 | 2/2/26 | ALKS | Alkermes Plc. | | Health | Drug | Pharmaceutical Preparations | Cooke Shane | | D | | 2 | M.d | 4,052 | 33.10 | 0 | 122 | | 104 | D | | | | | | | | | | | | | | |
2/2/26 20:48 | 2/2/26 | ALKS | Alkermes Plc. | | Health | Drug | Pharmaceutical Preparations | Cooke Shane | | D | | 2 | S.d | -4,052 | 33.10 | 0 | -122 | | 104 | D | | | | | | | | | | | | | | |
2/2/26 18:59 | 2/2/26 | ABEO | Abeona Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wuchterl Donald A. | OH | D | | 1 | S | -75 | 5.09 | 0 | -15 | | 168 | D | | | | | | | | | | | | | | |
2/2/26 18:55 | 2/2/26 | ABEO | Abeona Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Crombez Eric | OH | D | | 1 | S | -83 | 5.09 | 0 | -16 | | 63 | D | | | | | | | | | | | | | | |
2/2/26 18:30 | 2/2/26 | AXSM | Axsome Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Tabuteau Herriot | NY | DOT | CEO | 6 | M.dm | 43,565 | 86.51 | 0 | 504 | 7 | 7,352 | D | | | | | | | | | | | | | | |
2/2/26 18:30 | 2/2/26 | AXSM | Axsome Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Tabuteau Herriot | NY | DOT | CEO | 6 | S.dm | -43,565 | 86.51 | 0 | -504 | | 7,352 | D | | | | | | | | | | | | | | |
2/2/26 18:11 | 2/2/26 | XERS | Xeris Biopharma Holdings, Inc. | | Health | Drug | Pharmaceutical Preparations | Hecht Beth | IL | O | See Rema | 4 | S.d | -488 | 7.32 | 0 | -67 | | 1,337 | D | | | | | | | | | | | | | | |
2/2/26 17:19 | 1/30/26 | ZVRA | Zevra Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Thompson Rahsaan | FL | OH | Chief Le | 2 | M.d | 36 | 2.34 | 0 | 15 | 45 | 50 | D | | | | | | | | | | | | | | |
2/2/26 17:19 | 1/30/26 | ZVRA | Zevra Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Thompson Rahsaan | FL | OH | Chief Le | 2 | S.d | -36 | 2.34 | 0 | -15 | | 50 | D | | | | | | | | | | | | | | |
2/2/26 17:19 | 1/30/26 | ZVRA | Zevra Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Quartel Adrian W | FL | O | Chief Me | 2 | M.d | 40 | 2.52 | 0 | 16 | | 10 | D | | | | | | | | | | | | | | |
2/2/26 17:19 | 1/30/26 | ZVRA | Zevra Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Quartel Adrian W | FL | O | Chief Me | 2 | S.d | -40 | 2.52 | 0 | -16 | | 10 | D | | | | | | | | | | | | | | |
2/2/26 17:18 | 1/31/26 | ZVRA | Zevra Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | McFarlane Neil F. | FL | DO | P,CEO | 2 | M.d | 853 | 2.63 | 0 | 324 | 811 | 364 | D | | | | | | | | | | | | | | |
2/2/26 17:18 | 2/2/26 | ZVRA | Zevra Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | McFarlane Neil F. | FL | DO | P,CEO | 2 | S.d | -853 | 2.63 | 0 | -324 | | 364 | D | | | | | | | | | | | | | | |
2/2/26 16:59 | 1/30/26 | RPRX | Royalty Pharma Plc | X0 | Health | Drug | Pharmaceutical Preparations | Urist Marshall | NY | O | EVP,Rese | 10 | S | -9,610 | 39.52 | 0 | -243 | | 228 | I | | | | | | | | | | | | | | |
2/2/26 16:30 | 1/29/26 | NUVL | Nuvalent, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Noci Darlene | MA | O | Chief De | 7 | M.dm | 2,493 | 72.44 | 0 | 34 | 145 | 58 | D | | | | | | | | | | | | | | |
2/2/26 16:30 | 1/29/26 | NUVL | Nuvalent, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Noci Darlene | MA | O | Chief De | 7 | S.dm | -2,493 | 72.44 | 0 | -34 | | 58 | D | | | | | | | | | | | | | | |
2/2/26 16:30 | 2/2/26 | ABEO | Abeona Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Alland Leila | OH | D | | 1 | S | -92 | 5.09 | 0 | -18 | | 174 | D | | | | | | | | | | | | | | |
2/2/26 16:30 | 2/2/26 | ABEO | Abeona Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Alvino Mark | OH | D | | 3 | S | -152 | 4.98 | 0 | -31 | | 84 | D | | | | | | | | | | | | | | |
2/2/26 16:15 | 1/30/26 | ALT | Altimmune, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Garg Vipin K | MD | D | | 3 | M.d | 0 | 0.00 | 0 | 110 | 35 | 425 | D | | | | | | | | | | | | | | |
2/2/26 16:08 | 1/30/26 | APRE | Aprea Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gilad Oren | PA | DO | P,CEO | 1 | P.d | 25 | 0.8900 | 0 | 28 | 8 | 376 | D | | | | | | | | | | | | | | |
2/2/26 16:05 | 1/30/26 | APRE | Aprea Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hamill John P. | PA | O | SrVP,CFO | 2 | P.d | 11 | 1.02 | 0 | 11 | 47 | 33 | D | | | | | | | | | | | | | | |
1/30/26 20:39 | 1/30/26 | NRIX | Nurix Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | 2 | M.d | 61 | 4.01 | 0 | 15 | 50 | 45 | D | | | | | | | | | | | | | | |
1/30/26 20:39 | 1/30/26 | NRIX | Nurix Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | 2 | S.d | -61 | 4.01 | 0 | -15 | | 45 | D | | | | | | | | | | | | | | |
1/30/26 20:38 | 1/30/26 | NRIX | Nurix Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | 8 | M.d | 936 | 8.89 | 0 | 105 | | 57 | D | | | | | | | | | | | | | | |
1/30/26 20:38 | 1/30/26 | NRIX | Nurix Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | 8 | S.d | -936 | 8.89 | 0 | -105 | | 57 | D | | | | | | | | | | | | | | |
1/30/26 16:52 | 1/28/26 | CTNM | Contineum Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watkins Tim | CA | O | CMO,Head | 4 | M.d | 127 | 8.81 | 0 | 14 | | 0 | D | | | | | | | | | | | | | | |
1/30/26 16:52 | 1/28/26 | CTNM | Contineum Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watkins Tim | CA | O | CMO,Head | 4 | S.d | -127 | 8.81 | 0 | -14 | -100 | 0 | D | | | | | | | | | | | | | | |
1/29/26 20:05 | 1/29/26 | SRPT | Sarepta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Nicaise Claude | MA | D | | 1 | M.d | 144 | 13.71 | 0 | 11 | 50 | 32 | D | | | | | | | | | | | | | | |
1/29/26 20:04 | 1/27/26 | SRPT | Sarepta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Behrens M Kathleen | MA | D | | 1 | M.d | 144 | 13.71 | 0 | 11 | 5 | 207 | D | | | | | | | | | | | | | | |
1/29/26 19:32 | 1/28/26 | AIMD | Ainos, Inc. | TX | Health | Drug | Pharmaceutical Preparations | Taiwan Carbon Nano Technology Corp | F5 | T | | 2 | S.m | -102 | 2.16 | 0 | -47 | | 1,036 | D | | | | | | | | | | | | | | |
1/29/26 16:57 | 1/28/26 | KPTI | Karyopharm Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Abate Kristin | MA | O | Chief Ac | 2 | S | -2 | 6.13 | 0 | 0 | | 23 | D | | | | | | | | | | | | | | |